https://www.sonalasense.com/news/arpa-h-funds-sonalasense-to-develop-sonodynamic-therapy-to-revolutionize-treatment-of-blood-cancers- 2024-12-11 https://www.sonalasense.com/news/sonalasense-presents-preliminary-data-from-clinical-study-in-patients-with-deadly-pediatric-brain-tumor- 2023-12-13 https://www.sonalasense.com/news/fda-grants-fast-track-designation-to-sonalasense%E2%80%99s-sonala-001-in-combination-with-the-insightec-transcranial-ultrasound-device-for-sonodynamic-therapy-of-dipg%2C-a-rare-pediatric-brain-cancer 2023-11-14 https://www.sonalasense.com/news/cancer-commons-and-sonalasense%3A-putting-patients-first 2023-08-17 https://www.sonalasense.com/news/a-few-minutes-with-dipg-nurse-navigator-leslie-jared 2023-07-27 https://www.sonalasense.com/news/view-video%3A-our-director-of-patient-advocacy-moderated-an-insightful-panel-discussion-at-the-white-house-cancer-moonshot-brain-cancers-forum-on-gbm-%26-dipg-on-may-25%2C-2023 2023-05-25 https://www.sonalasense.com/news/sonalasense-welcomes-dr.-ely-benaim-as-chief-medical-officer-and-executive-vice-president-of-development 2023-05-09 https://www.sonalasense.com/news/sonalasense-announces-completion-of-first-cohort-in-phase-2-study-of-sonala-001-sonodynamic-therapy-for-recurrent-glioblastoma 2023-03-08 https://www.sonalasense.com/news/fast-company%E2%80%99s-%E2%80%98world-changing-ideas-awards%E2%80%99-honorably-mentions-sonalasense 2023-03-08 https://www.sonalasense.com/news/dr.-stuart-marcus-creates-sonalasense-to-treat-deadly-cancers 2023-01-11 https://www.sonalasense.com/news/sonalasense-forges-ahead-with-first-patient-dosing-for-devastating-childhood-brain-cancer 2023-03-08 https://www.sonalasense.com/news/april-freeman-brings-her-personal-and-professional-experience-to-sonalasense-as-patient-advocate 2023-01-11 https://www.sonalasense.com/news/sonalasense-achieves-significant-clinical%2C-growth-and-funding-milestones-toward-its-mission-to-soundly-defeat-cancer 2023-03-08 https://www.sonalasense.com/news/sonalasense-q%26a-with-dr.-scott-plotkin 2023-01-11 https://www.sonalasense.com/news/ivy-brain-tumor-center-and-sonalasense-announce-positive-initial-results-of-the-first-in-human-phase-0%2F1-clinical-trial-of-non-invasive-sonodynamic-therapy-for-recurrent-glioblastoma 2023-03-08 https://www.sonalasense.com/news/the-ins-and-outs-of-glioblastoma-from-standard-of-care-to-breakthrough-treatments-for-brain-tumor-patients 2023-03-08 https://www.sonalasense.com/news/ivy-brain-tumor-center%2C-sonalasense-and-insightec-announce-the-first-patient-dosed-in-first-in-human-clinical-trial-of-noninvasive-sonodynamic-therapy-for-the-treatment-of-brain-cancer 2023-03-08 https://www.sonalasense.com/news/sonalasense-pioneers-sonodynamic-therapy%2C-a-first-in-class-noninvasive-therapy-for-lethal-brain-cancers%3B-enters-into-a-collaboration-and-license-agreement-with-insightec-and-a-collaboration-agreement-with-ivy-brain-tumor-center-to-conduct-the-first-in-man-clinical-trial-for-recurrent-glioblastoma 2023-03-08 https://www.sonalasense.com/news/the-brain-race-announces-winning-startups-in-position-to-defeat-brain-tumors 2023-03-08